US stocks on the move: Nvidia, Genmab, Eli Lilly
NVDA•Nvidia shares fell as its board probed CEO Jensen Huang over spy claims. Genmab rose after partner Johnson & Johnson received FDA approval for a cancer drug, while Jefferies raised its price target for Eli Lilly, saying its ex-US GLP-1 opportunity is underestimated.
1. Stock moves
Nvidia shares fell as its board probed CEO Jensen Huang over spy claims. Genmab rose after partner J&J received FDA approval for a cancer drug. Jefferies lifted its price target for Eli Lilly, saying the company's ex-US GLP-1 opportunity is underestimated.
